Reviewing Virax Biolabs Group (NASDAQ:VRAX) and Lucira Health (NASDAQ:LHDXQ)

Financial News Live ·  Apr 20, 2023 10:04

Virax Biolabs Group (NASDAQ:VRAX – Get Rating) and Lucira Health (NASDAQ:LHDXQ – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

Valuation & Earnings

This table compares Virax Biolabs Group and Lucira Health's top-line revenue, earnings per share (EPS) and valuation.

Get Virax Biolabs Group alerts:
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Virax Biolabs Group $120,000.00 72.57 -$1.71 million N/A N/A
Lucira Health $93.06 million 0.05 -$64.83 million ($3.58) -0.03

Virax Biolabs Group has higher earnings, but lower revenue than Lucira Health.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Virax Biolabs Group and Lucira Health, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Virax Biolabs Group 0 0 0 0 N/A
Lucira Health 0 0 0 0 N/A

Institutional & Insider Ownership

0.5% of Virax Biolabs Group shares are held by institutional investors. Comparatively, 57.0% of Lucira Health shares are held by institutional investors. 45.1% of Virax Biolabs Group shares are held by insiders. Comparatively, 30.4% of Lucira Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.


This table compares Virax Biolabs Group and Lucira Health's net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Virax Biolabs Group N/A N/A N/A
Lucira Health -67.54% -13.55% -8.47%


Virax Biolabs Group beats Lucira Health on 6 of the 8 factors compared between the two stocks.

About Virax Biolabs Group

(Get Rating)

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

About Lucira Health

(Get Rating)

Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.

Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment